Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy.

Sci Rep · 2022 · PMC8863801 · PMID 35194060

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Correctively, between the C group and the N group, we observed a moderate reduction of LVEF and LVSV, no difference in LVEDV, and an increasing trend of LVM, suggesting that steatohepatitis-related cardiomyopathy was characterized by modestly disturbed LV wall motion with concentric hypertrophy.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.